Biotech Values

[mcbio]

The idea this small company could solve the delivery issues plaguing RNAi was also hard to stomach.

Per slide 18 of their corporate presentation, ARWR actually claims it "is the first company to have successfully systemically administered sIRNAs and the only biotech that showed clinical success in anything other than liver." Seems to be a pretty bold statement. Not sure what this is based on and whether or not this is 100% accurate.

So now they are a "homing peptide" company.

They are a couple of things now. The homing peptides came through the acquisition of Alvos. Obviously their RNAi focus came from buying the Roche RNAi assets.

Happy New Year to you and all the other bio-junkies on BV.

Same to you and everyone on here!